Lax rules that allow people to buy asthma reliever inhalers in retail pharmacies without medical supervision is contributing to widespread overuse of short-acting beta-agonists (SABA), Australian research suggests. A survey of 412 people who bought a SABA inhaler over the counter from a retail pharmacy found that 289 (70%) were overusers, as defined by inhaler ...
‘Extreme’ SABA overuse seen with pharmacy OTC inhalers
By Michael Woodhead
15 Aug 2019